Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lei Xu, M.D., Ph.D.

Concepts (350)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Lei Xu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Lei Xu has written about over time.
Lymphokines, 4 publications between 2001 and 2011, average publication date March 2005. Platelet-Derived Growth Factor, 2 publications between 2005 and 2011, average publication date May 2008. Pregnancy Proteins, 4 publications between 2006 and 2013, average publication date September 2008. Vascular Endothelial Growth Factor A, 12 publications between 2001 and 2017, average publication date January 2009. Neovascularization, Pathologic, 13 publications between 2002 and 2019, average publication date March 2009. Receptors, CXCR4, 3 publications between 2009 and 2011, average publication date September 2010. Neuropilin-1, 2 publications between 2009 and 2013, average publication date June 2011. Transforming Growth Factor beta, 2 publications between 2011 and 2012, average publication date November 2011. Ascites, 2 publications between 2011 and 2019, average publication date January 2015. Peripheral Nervous System Neoplasms, 1 publications between 2017 and 2017, average publication date September 2017. Disease Models, Animal, 10 publications between 2006 and 2024, average publication date September 2017. Proto-Oncogene Proteins c-met, 1 publications between 2018 and 2018, average publication date February 2018. Neuroma, Acoustic, 5 publications between 2015 and 2020, average publication date March 2018. Stromal Cells, 1 publications between 2019 and 2019, average publication date January 2019. Cerebellopontine Angle, 1 publications between 2019 and 2019, average publication date February 2019. Neurofibromatosis 2, 6 publications between 2015 and 2023, average publication date April 2019. Neurofibromin 2, 5 publications between 2015 and 2023, average publication date May 2019. Hearing Loss, 3 publications between 2018 and 2021, average publication date July 2019. Losartan, 3 publications between 2019 and 2023, average publication date March 2021. Neurilemmoma, 4 publications between 2018 and 2023, average publication date June 2021.

To see the data from this visualization as text, click here.
Xu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (350)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.